Abstract Copper plays an important role in numerous biological processes across all living systems predominantly because of its versatile redox behavior. Cellular copper homeostasis is tightly regulated and disturbances lead to severe disorders such as Wilson disease and Menkes disease. Age-related changes of copper metabolism have been implicated in other neurodegenerative disorders such as Alzheimer disease. The role of copper in these diseases has been a topic of mostly bioinorganic research efforts for more than a decade, metal-protein interactions have been characterized, and cellular copper pathways have been described. Despite these efforts, crucial aspects of how copper is associated with Alzheimer disease, for example, are still only poorly understood. To take metal-related disease research to the next level, emerging multidimensional imaging techniques are now revealing the copper metallome as the basis to better understand disease mechanisms. This review describes how recent advances in X-ray fluorescence microscopy and fluorescent copper probes have started to contribute to this field, specifically in Wilson disease and Alzheimer disease. It furthermore provides an overview of current developments and future applications in X-ray microscopic methods.
Introduction
Metals and their involvement in health and disease are of evergrowing importance in biomedical research. Lighter elements such as calcium participate in complex signaling pathways that are still being unraveled, whereas transition metals are often cofactors in proteins, where they undergo chemical state alterations (i.e., redox reactions) in the enzymatic reactions they facilitate. Although the reactivity of metals is of great use for facilitating enzymatic reactions, it also requires strict control to mitigate toxicity. Therefore, metal homeostasis is tightly managed by cells and any disturbance leads to severe consequences. A comprehensive metallomic study would typically entail choosing a pathway for a specific metal and then investigating metal concentration, distribution, and metalprotein binding as well as changes thereof in healthy individuals and in disease. Whereas measuring bulk metal concentrations and exploring metal-protein interactions employ established methods and instrumentation, reliable, userfriendly techniques to produce spatially resolved data on metal content in biological specimens have largely emerged only during the past 10 years. Examples are synchrotron-based Xray fluorescence microscopy (XFM), fluorescent metal sensors, secondary ion mass spectrometry (SIMS) and nano-SIMS, laser ablation inductively coupled mass spectrometry (LA-ICPMS), electron probe X-ray microanalysis (EPXMA), and proton-induced X-ray emission (PIXE) (for a recent review of these methods and their application to metallomic studies in neurodegenerative diseases, see [1] ).
This report will review recent progress in investigation of the metallome of mammalian copper with respect to unraveling the disease mechanisms of two human disorders: Wilson disease (WD) and Alzheimer disease. We will specifically discuss contributions to this field made by imaging techniques, predominantly XFM studies and fluorescent copper sensors. We will furthermore describe new methods and developments in X-ray fluorescence tomography, XFM imaging at the nanoscale, and provide a perspective on sample preparation.
Imaging methods
X-ray-based microscopy X-ray microscopy (XRM) and specifically synchrotron-based XRM methods are increasingly used either alone or in combination with other correlative techniques to image cellular, organelle, or elemental structures in biology. The advantage of using X-rays in biological imaging is based on their penetration depth, which allows imaging of cells or tissue close to or in the native state rather than bulk or homogenized and fractionated samples. Advances in focusing optics have resulted in microscopes with 20-nm resolution, and tomographic reconstructions allow three-dimensional imaging. Some correlative approaches such as fluorescent microscopy allow targeting of regions of interest prior to measurement, whereas others, such as Fourier transform infrared microspectroscopy (FTIRM), are used to complement XRM information with chemical properties.
Two main classes of XRM outline the two major applications. Soft X-rays (2-5-nm wavelength) are used to measure the intrinsic phase contrast of lighter elements, i.e., detecting cellular and intracellular structures such as organelles. Detection is performed in transmission mode, with the detector located in-line with the X-rays and the sample. Because of limited penetration of soft X-rays, samples have to be about 10 μm. Hard X-rays in combination with Zernike phase contrast techniques enable users to perform X-ray tomography on thicker samples (more than 10 μm). The resulting hard X-ray phase contrast images are often used in combination with XFM, a technique that will yield quantitative information with high spatial resolution on the elemental distribution (see later).
Chemical state mapping (X-ray absorption near-edge spectroscopy) X-ray absorption near-edge spectroscopy (μXANES) is an attractive method to gain information about an element's redox status when imaging biological material. To determine oxidation states of metals, a stationary focused X-ray beam (usually 5 μm × 5 μm) is applied to a target cell or tissue sample and the absorption of X-ray photons is monitored while scanning the energy through the X-ray absorption edge of the element under investigation. The position of the edge (its first inflection point) and the shape of the edge (specifically "pre-edge features") contain information about the oxidation state and often the coordination sphere. Data analysis is still almost exclusively performed in an empiric manner by comparing experimental data with measured model compounds. Several groups have successfully determined the oxidation states of mostly iron and copper in biological specimens [2] [3] [4] (for a recent review, see Ortega et al. [5] ). A nice example is a more recent publication by Glasauer et al. [2] , who studied the oxidation state of iron in cytoplasmic granules in Shewanella putrefaciens that are formed during anaerobic respiration and found iron to be in a mixed-valence state. Yang et al. [4] determined the oxidation state of copper in a mouse fibroblast cell line that had been exposed to 200 μM CuCl 2 . Their results indicated that copper is predominantly present as Cu(I) in a linear to trigonal coordination arrangement with mostly sulfur.
Although the experimental setup and data analysis for μ-XANES is straightforward, literature examples are still rare. Longer dwell times (the sample remains stationary during a 5-10-min scan) with highly brilliant, focused Xrays induce significant photoreduction and radiation damage, and XANES measurements therefore have to be evaluated carefully. Lastly, even a small beam size of 5μm × 5μm will contain multiple proteins and the resulting XANES spectrum will be a representation of the average oxidation state, which is mostly likely dominated by a metals bound to a highabundance storage protein.
X-ray fluorescence microscopy XFM is part of the XRM super group and is rapidly becoming the method of choice for an ever-growing community of bioanalytical researchers to probe trace elements in biological systems. It is used for both, quantitative visualization and analysis of the local chemical state of elements of interest (for in depth reviews of XFM, see [5] [6] [7] [8] [9] [10] [11] [12] ). Briefly, hard Xrays (10 keV or greater), with an incident energy chosen to be above the relevant absorption edges of the elements of interest, are focused onto the specimen, inner (K-or L-shell) electrons are knocked out, and the subsequent relaxation process causes X-ray fluorescence characteristic for the absorbing element. An energy-dispersive detector system is usually used to record a full X-ray spectrum at each scan position and elemental maps for ten or more chemical elements are then derived from these spectra. A scheme illustrating the experimental setup for XFM experiments is depicted in Fig. 1 . The spatial resolution achievable is generally determined by the X-ray optics used; values that are routinely achieved today with a variety of instruments are in the micrometer range for Kirkpatrick-Baez mirror systems and on the order of hundreds of nanometers for systems based on Fresnel zone plates. Several systems have the capability to achieve spatial resolution well below 100 nm [12] [13] [14] . In recent years there have been significant improvements not only in X-ray optics, but also in detector and data acquisition systems, permitting, among other things, much more rapid data collection with significantly reduced overhead [15] . In terms of biological applications, XFM is a convenient probe to explore the elemental content of cells and tissue but it has also been shown to be a powerful tool in determining regulatory changes in cells and tissues. Chen et al. [16] used XFM to confirm that cisplatin is sequestered in melanosomes in melanoma cells instead of nuclear targeting. The melanosomes were subsequently exported, explaining the underlying mechanism of multidrug resistance in patients with melanoma. Finney et al. [17] demonstrated dynamic changes in the copper distribution in breast cancer cells. They found that copper relocates to the extracellular space during angiogenesis, and on the basis of these results suggested that copper has a regulatory role in the process of angiogenesis.
XFM imaging at the nanoscale and sample preparation
Several institutions are pursuing the development of nextgeneration X-ray fluorescence microprobes that facilitate imaging of trace metal content in biological systems at the highest spatial resolution, in the range from 20-50 nm, with samples preserved as similarly as possible to the natural state. Radiation damage is generally manageable in XFM (dwell times are relatively short) its effects can, however, directly limit the spatial resolution achievable (see [18] for a discussion of the relation between the dose required for imaging and structural damage to the sample). To mitigate the effects of radiation damage, the sample must therefore be adequately preserved. Although chemical fixation can work well for structural studies, it often interferes with the elemental content and can cause significant redistribution of elements, in particular for diffusible ions [19, 20] . The method of choice to preserve the elemental content, such as the copper distribution, is cryofixation, preferably through plunge freezing into liquid nitrogen cooled liquid ethane (for thin samples) or high-pressure freezing for thick samples. This way, vitrification is achieved without the creation of ice crystals that would damage the structure of the specimen. Although subsequent freeze-drying and imaging of the sample at room temperature is a reasonable approach for investigations requiring moderate spatial resolution, freeze-drying neither preserves the true threedimensional structure of the specimen well nor its ultrastructure best. To make the best use of the strengths of XFM, such as high penetration depth, a spatial resolution that is maintained through comparatively thick samples (as long as they are within the depth of focus of the optics used), and low background, but that at the same time minimizes self absorption artifacts for low-Z fluorescence, good samples thicknesses would be on the order of 10 μm, well matched to typical cell sizes. To exploit the recent advances, and facilitate high-resolution trace metal mapping, several different approaches have been implemented. Vacuum systems [13, 21] have the advantage of minimized background and minimum absorption of low-Z elemental fluorescence, but require dedicated instrumentation. Approaches that work in ambient conditions permit more flexible use of the microprobe but are not optimized for low-Z element detection. One such approach is the use of a separated, cryocooled stage [12] , and another one is the use of a cryojet [22] , similarly to methods in macromolecular crystallography.
Three-dimensional XFM
Since hard X-ray microprobes typically have a large depth of focus (100 μm or greater), and the lateral spatial resolution does not deteriorate throughout the specimen, elemental maps acquired from the sample are projection images integrating the elemental content through the thickness of the sample, i.e., a three-dimensional object is projected into a two-dimensional plane. Interpretation of such an elemental map can be challenging, especially if the thickness exceeds more than one cell layer or at high spatial resolutions, because of multiple overlapping structures. In these cases it is desirable to visualize the elemental content of a sample in three dimensions. When data are collected for three- Fig. 1 The experimental setup for XFM experiments dimensional XFM, numerous projection images are acquired for different projection angles to reconstruct the full tomographic representation of the specimen. This technology is still facing some challenges with regard to routine implementation [23] , but there have already been a number of impressive applications [24] [25] [26] and exciting advances have been made in recent years. An example is shown in Fig. 2: de Jonge et al. [24] visualized the three-dimensional elemental distribution for the diatom Cyclotella meneghiniana as a proof-of-concept study. They achieved 400-nm resolution and were able to calculate concentrations of biologically relevant elements. The frustule is composed mainly of silicon, with less abundant copper and zinc. Phosphorous, potassium, and calcium were shown to accumulate in three distinct nuclei, whereas manganese and iron were shown to localize to ringshaped patterns around the diatom.
Several new or upgraded instruments are in various stages from conception, to implementation, to commissioning, to operation, promising the ability to image trace elemental content in frozen-hydrated biological specimens with spatial resolutions below 50 nm, in three dimensions. Several synchrotron radiation facilities have either come online recently or are in various stages of being built or upgraded, and offer valuable additional improvements in instrument performance through increased brightness and thereby focused flux on the sample and corresponding improved throughput. These instrumentation advances, together with source and detector developments, as well as method development such as the application of dose fraction approaches [27] towards XFM promise to allow full three-dimensional visualization of trace elemental content of single cells [23] .
Such advances will significantly improve our ability to investigate elements such as copper in biological systems close to their natural state within organelles, and will facilitate new studies with a potentially significant impact on our understanding of the multitude of roles that these elements play. 1 
Quantitation
XFM is inherently quantitative and application software developments allow users to quickly assess elemental concentrations in their samples [31, 32] . Quantitation and concentration measurements with XFM are based on the fact that the X-rays penetrate the entire sample (typically in the range of 10 μm (high, submicrometer resolution) to 50 μm (low, micrometer resolution) thickness). Standard X-ray reference materials are used to correlate the fluorescent photon counts to area concentrations (μg/cm 2 ), though standardless quantification is also possible. Resulting area concentrations are converted into volume concentrations if the thickness of the sample is known. If whole cells are imaged, elemental concentrations are often expressed as micrograms per cell.
Correlative techniques to complement XFM
XFM is based on the fluorescence of elements, and is particularly sensitive to heavier elements (Z≥14). As a consequence, cellular structures such as membranes cannot be easily recognized unless different cellular compartments contain substantially different amounts of one element. Nuclei, for example, can often be identified by the comparably higher abundance of phosphorous (Fig. 3) . In order to co-localize the elemental content with cellular substructures such as organelles, XFM has to overcome the lack of contrast artificially by either applying other spectroscopic techniques to the same samples, making use of phase contrast [33] [34] [35] , or using appropriate biomarkers labeled with a heavy, nonphysiologically relevant element. Leskovjan et al. [36] [37] [38] and Miller et al. [39, 40] routinely employ FTIRM where the relative protein content of an area is determined by integrating the spectrum from 1,490 to 1,580 cm -1 , the absorption range for the protein-specific amide II band. FTIRM measurements are conducted on the same samples after the XFM experiments. McRae et al. [41] used FluoroNanogold [42, 43] , where secondary antibodies carry a 1.4-nm gold cluster in addition to a fluorophore. FluoroNanogold-labeled antibodies against mitochondria and the Golgi apparatus were visualized via the gold cluster and subsequently co-localized with copper in the initial proof-of-concept study. Endres et al. [44] [45] [46] showed how organic gadolinium magnetic resonance probes can function as contrast agents for intracellular locations, whereas Paunesku et al. [47, 48] tracked the titanium signature from TiO 2 nancomposites that are used as an intracellular drug delivery vehicle. Lastly, Corezzi et al. [49] employed commercially available secondary CdSe/ZnS quantum dot antibodies against the human cancer marker Her2 and β-tubulin and followed the selenium signature in a cancer cell line. Another promising option for organelle labeling are lanthanide (Ln 3+ ) containing conjugates for primary antibodies. Developed as markers for mass cytometry [50] , the Ln 3+ (such as Pr 3+ or Sm 3+ ) conjugates consist of metal-chelating polymers that are attached to primary antibodies via a reduced thiol group onto the Fc fragment of the antibody (Fig. 4a) . Each polymer carries about 30 Ln 3+ ions and between four and six polymers are bound to one protein molecule. Therefore, a total of 120-130 Ln 3+ ions are attached to each antibody. During the actual XFM experiment, the Ln 3+ distribution is monitored and co-localized with other metals of interest. The hypothetical application of these markers is illustrated in Fig. 4b and c. Figure 4b shows a false-color image of fibroblasts labeled with 4′,6-diamidino-2-phenylindole (blue, nuclei) and anti-TG46, a marker for the trans-Golgi network (red). No information on the copper distribution is available. Figure 4c shows a hypothetical XFM map consisting of an overlay for the elements phosphorous (red, nuclei), copper (blue), and praseodymium (green, praseodymium-anti-TG46 conjugate). A major advantage of this method is the convenient location of the Ln 3+ L edge's emission line. For Pr 3+ or Sm
3+
, for example, this range is between 5 and 7 keV, which is well suited for typical XFM experiments, where the maximum instrument sensitivity is just above the zinc K edge (10-keV incident X-ray energy). Additionally, the use of a conjugated primary antibody rather than a secondary antibody decreases the sample handling time and eliminates another source of nonspecificity.
Fluorescent copper sensors
To monitor fluxes of labile copper in living systems, several research groups developed copper-sensitive fluorescent probes and successfully tested them on cells [4, [51] [52] [53] [54] [55] and, recently, tissue [56] . Although the cytosolic levels of unbound copper are below one copper ion per cell, the rapid rate by which this concentration can change suggests that some of this copper is easily accessible. The cytosolic copper concentration in fibroblasts, for example, increases threefold or tenfold when the growth medium is supplemented with 100 μM copper for 4 or 48 h, respectively. Fluorescent copper sensors are usually membranepermeable probes that consist of two π-electron systems (a copper-binding moiety and a fluorophore) separated and thus electronically disconnected by a short alkyl chain linker. In the unbound state, the fluorescence is quenched by fast photoinduced electron transfer from or to the fluorophore. When copper binds, the redox properties of the binding unit are altered. The photoinduced electron transfer process is slowed or stopped, thus resulting in fluorescence [57] . Early probes were hampered by their lack of sensitivity and Fahrni et al. showed that the fluorescent recovery upon Cu(I) binding can be incomplete owing to ternary quenching pathways [58] . His group subsequently addressed this and developed a highcontrast probe in which the fluorescent enhancement upon saturation is greater than 200-fold, in contrast with a fivefold increase for their earlier probes [4, 58, 59] . These probes, however, have so far not been tested in in vivo systems. Chang's group [56] recently reported the synthesis and application of a copper sensor (CS790) with near-infrared emission at 790 nm. The 15-fold fluorescent enhancement of their probe was sufficient to monitor labile copper in Atp7b −/− mice (see later).
The copper metallome
Copper is an essential trace element that is important in numerous biological processes. Its low electrochemical half-cell potential, 150 mV for Cu(II)/Cu(I), and 300-550 mV in proteins [60] , makes it a versatile tool in enzymatic reactions, including electron transfer or redox chemistry. This versatility also renders unbound or "free" copper a potential hazard. It promotes the formation of reactive oxygen species such as hydroxyl radicals via abstraction of electrons from H 2 O 2 [61] . Copper levels are tightly regulated to support physiological requirements and prevent buildup of toxic levels; the cellular content of "free" copper is maintained at less than one copper ion per cell [62, 63] . Any disturbance of this regulatory process leads to severe consequences. Wilson disease and Menkes disease are directly caused by copper accumulation or deficiency, respectively, through inactivation of the copper exporting P 1B -type ATPases ATP7b (Wilson disease) and ATP7a (Menkes disease) [64, 65] . The association of copper in neurodegenerative diseases has been discussed in a plethora of articles (for a recent comprehensive review, see [66] ).
Copper-binding proteins can be divided into two major classes, those which use copper for specific functions (copper enzymes, class I) and those which facilitate copper transport, transfer, and storage (class II) [60, 67] . The sophisticated pathways for the latter class have been extensively studied in both eukaryotic and prokaryotic systems and are described in several reviews [62, [67] [68] [69] . It was further shown that the regulation of copper and iron (at least in mammals) is intertwined [70] . Although research over the past 20 years has greatly advanced our knowledge of copper proteins and their pathways, disease-related changes in these pathways remain largely elusive. This is in part also why it remains unclear how copper is associated with neurodegnerative diseases, for example, Alzheimer disease, as these are not caused by or involve a singular copper protein. The more general but nonetheless complex question of how nongenetic causes and disturbances of copper regulation and pathways contribute to ailments such as cancer, Alzheimer disease, and inflammation remains unanswered. Research targeting this question has to include a global approach: changes in organ, cellular, and intracellular copper distribution, concentration, and chemical state have to be considered. Bioanalytical sciences have to transition from a one-dimensional, protein-specific approach to a two-and three-dimensional approach. We will describe research advances for the copper metallome as a consequence of developments in multidimensional imaging methods. We will focus on Wilson disease and Alzheimer disease, two neurodegenerative disease of substantially different origin.
Copper homeostasis in Wilson disease and Menkes disease
Wilson disease is a genetic disorder of copper metabolism associated with severe hepatic, neurological, and psychiatric abnormalities. A major hallmark of Wilson disease is the accumulation of copper in liver and frequently in basal ganglia. The gene affected, ATP7B, which encodes a coppertransporting ATPase, was identified in 1993 [64, 71] . The protein, ATP7b, has been extensively studied [69, 72] . Under basal copper conditions it localizes to the trans-Golgi network and transports copper across the membrane to be incorporated into ceruloplasmin [73] . Upon elevation of intracellular copper levels, ATP7b relocates into vesicles close to the apical membrane and for biliary excretion [74, 75] . ATP7b is the only known hepatic copper exporter, and consequently its inactivation leads to accumulation of copper. Wilson disease can present with a clinical syndrome indistinguishable from chronic hepatitis or advanced cirrhosis of other origin [76] . The only reliable biochemical indicator of Wilson disease is greatly elevated copper levels in liver biopsy samples (more than 250 μg/g dry tissue weight compared with 20-50 μg/g dry tissue weight in controls [77, 78] ). However, the level of copper per se does not correlate with either the stage or the severity of the disease. Genetically engineered ATP7b null mice confirmed the complex genotype-phenotype relationship [79] [80] [81] . It was shown that the knockout mice do not start to exhibit substantial cellular damage until after the copper levels have peaked at 6 weeks of age. Significant changes in morphology are typically not observed until 12 weeks of age. In Menkes disease, an X-linked genetic disorder, newborns are incapable of absorbing copper from the small intestine, and therefore develop a copper deficiency. The defective protein in Menkes disease, ATP7a, has more than 40 % sequence identity with ATP7b and is expressed in most cells, with the notable exception of hepatocytes [65, 82] . Similar to ATP7b, ATP7a resides in the trans-Golgi network at basal copper levels and relocates to the proximity of the basolateral membrane to aid in copper export when levels are elevated [83] . Because ATP7a plays a critical role in copper uptake from the small intestine, its dysfunction will lead to severe copper deficiency and usually death at the age of 3 years.
Elucidating the copper metallome for Wilson disease
Histological copper staining of liver sections from Wilson disease patients showed accumulated copper in the periportal regions in the early stages of the disease, whereas at later stages copper was diffusely distributed in each lobule [84, 85] . Other groups suggested that the intracellular localization of copper changes from mainly cytosolic in the early disease stages to predominantly lysosomal and nuclear in the later stages [86] [87] [88] . However, it was shown that histological stains for copper are unreliable: it appears that they only detect unbound or loosely bound copper [1, 9] . In recent years researchers have utilized ATP7b null and control mice, which greatly increased the sampling size and ensured a controlled environment [79] .
Using XFM, Ralle at al. [89] proposed a mechanism for copper accumulation that could explain the delayed onset of morphological changes in ATP7b −/− livers. In the initial stages of Wilson disease, massive amounts of copper enter the hepatocytes. Excess copper also enters the nucleus and triggers changes in the transcriptome. Later, copper recedes from the nucleus and other compartments (including the cytosol) and becomes concentrated in deposits. This copper redistribution (possibly into the lysosomes) was proposed as a selfprotection mechanism of the cell against copper toxicity. Hirayama et al. [56] demonstrated the ability of a fluorescent sensor, CS790, to monitor labile copper pools in cells and living mice, including ATP7b −/− mice. After testing the membrane-permeable version of CS790 on HEK293T cells (CS790-AM), Hirayama et al. injected 100 μM Cu(Cl) 2 solution into mice (ATP7b −/− mice and wild-type controls) 2 h prior to injection of CS790-AM and monitored the resulting increase in fluorescence caused by copper binding to the sensor. As expected, they found copper predominantly accumulating in the liver of the mice, with a higher fluorescent signal indicating a higher copper concentration originating from the liver of knockout mice. They also showed that upon administration of the copper chelator ATN-224, a compound that is currently discussed for treatment of Wilson disease, the fluorescent signal (radiant efficiency) decreased by a factor of 2-3. A similar study by Peng et al. [90] used positron emission tomography to track 64 Cu in Atp7b −/− mice and wild-type controls. Similar to Hirayama et al. Peng et al. demonstrated the liver to be the major site of copper accumulation, with impaired clearance for the knockout mice (0.8 h versus 2.5 h of mean residence time for hepatic copper in wild-type mice versus null mice). In addition, they reported an initial increase in clearance of copper from the kidney, an organ where both ATP7a and ATP7b are expressed. They argued that in the absence of ATP7b, ATP7a translocated from the basolateral to the apical membrane in a compensatory mechanism to relieve the increased burden of copper in the blood. Peng et al. were also able to monitor diffuse copper distribution in the intestines 2 h after injection of 64 Cu, which could be due to either higher sensitivity or better resolution of the positron emission tomography images (pixel size approximately 100 μm). The major difference between these two studies are the time points. Peng et al. monitored copper distribution starting immediately after injection, with two additional time points at 2 and 24 h after injection; Chang et al. only monitored one time point, at 2 h after injection. Regardless, both studies represent the first examples of determining copper distributions in Wilson disease knockout mice in vivo with sufficiently high spatial resolution. One possible future application for copper sensors is the localization of tumors in vivo as they show increased copper uptake. A copper-containing solution would be injected into the patient and the distribution of copper would be subsequently monitored.
Another protein important to understand the involvement of copper that plays a crucial in Wilson disease and Menkes disease is Atox1, the copper chaperone that delivers Cu + to ATP7a and ATP7b [91] [92] [93] . Atox1 binds Cu + in the same linear Cys-Cu-Cys fashion as the N-terminal binding regions of ATP7a and ATP7b [94] [95] [96] . McRae et al. [97] used synchrotron X-ray fluorescence imaging to determine the distribution of copper in an Atox1-deficient fibroblasts compared with wild-type cells when exposed to 50 μM copper. They reported that whereas copper preferably localized to the perinuclear region in Atox1 +/+ cells it was diffusely distributed throughout the cell in Atox1 
Copper in Alzheimer disease
Alzheimer disease is a progressive neurological disorder associated with extracellular amyloid β (Aβ) deposits, a peptide oligomerization, intracellular neurofibrillary tangles, synaptic toxicity, and oxidative stress. Although most of these processes or effects are understood individually, their complex, synergistic causes and consequences remain unclear.
A potential role of dyshomeostasis of metals was first proposed more than 60 years ago when Goodman [98] suggested a role for iron in Alzheimer disease. Goodman saw increased Prussian blue staining (a histological stain for iron) in postmortem tissues from Alzheimer disease patients. Since then numerous original articles and reviews on a possible involvement of metals in Alzheimer disease have been published (for more in-depth reviews, see [1, 49, 99, 100] ). Metallomics recently dedicated an entire issue to the role of metals in neurodegenerative disorders [66] . Iron, copper, and zinc have been identified to play a role in the mechanics of Aβ oligomer formation [100] [101] [102] ; they have been found in plaques and neurofibrillary tangles [100] , and are believed to be responsible for the widely observed oxidative stress in Alzheimer disease [103] . Despite this wealth of studies, much controversy exists about the specific role of metals, particularly copper, in key processes in Alzheimer disease, and how global changes in copper concentration affect progression of the disease. Even basic questions such as whether brains of individuals with Alzheimer disease exhibit elevated copper levels or rather a deficiency compared with healthy controls is the subject of discussion and controversy. Much of this is due to the complexity of the problem: the brain is a heterogeneous organ and changes in metal concentration will most likely be localized rather than global. Analyzing "local" metal concentrations with reasonable resolution (1μm × 1μm or less) across an entire human brain is time-consuming, and performing a longitudinal study of disease and control brains would take much longer. Schrag et al. [104] performed a meta-analysis of quantitative studies for iron, zinc, and copper in neocortical brain regions in postmortem human tissue. They concluded that the level of neither iron nor zinc was elevated and that the copper level was in fact decreased in Alzheimer disease subjects, which somewhat contradicts the conclusion of one of the most cited reviews on Alzheimer disease-metal research, by Bush [105] , who suggested a consensus in the literature for elevated metal concentrations in the brain of Alzheimer disease patients. Schrag et al. found that popular cited primary studies were qualitative, semiquantitative (i.e., used metal-toprotein ratios for quantitation), or used tissue unsuitable for quantitative analysis.
There are also difficulties when trying to define the role of metals at the protein level. Simple models have proven to be a lot more complicated than in vitro analysis suggested. Tougu et al. [106] examined the interaction of Cu(II) and Zn(II) with Aβ and subsequent oligomer and fibril formation. They outlined the complexity and dependency of reaction conditions used when examining the role of copper and zinc in Alzheimer disease. They concluded that both copper and zinc enhance as well as inhibit the formation of Aβ fibrils.
Significant progress to elucidate the role of copper (and other metals) in Alzheimer disease was made by spatially resolved, multidimensional techniques. Several studies determined the copper content in Aβ deposits (plaques). Lovell et al. [107] found 1.5-fold elevated levels of copper in plaques when compared with neuropil from human Alzheimer disease subjects using PIXE. Hutchinson et al. [108] used LA-ICPMS on sections derived from a transgenic mouse model and confirmed that the copper content was elevated in plaques (approximately fourfold). To identify Aβ deposits and correlate them with copper content, the mouse sections were stained with a europium-or nickelconjugated antibody. Similarly to Lovell et al., the imaged sections were fixed in paraformaldehyde, somewhat questioning the accuracy of the results as formalin fixation can significantly alter metal concentration and distribution in tissue [19] . Leskovjan et al. [36] and Miller et al. [39] performed the first spatially resolved study of copper levels in Aβ deposits from human plaques using cyro-fixed tissue. They used a combination of FTIRM and XFM on thioflavinstained sections and showed that the copper content was 1.8-fold elevated in human Aβ deposits. The first quantitative imaging study on cryofixed, unstained Aβ plaques was performed by Rajendran et al. [109] . Similarly to Lovell et al. [107] , they used PIXE for trace copper quantitation in plaques from brains of transgenic mice; however, instead of visualizing plaques by histochemical stains, they performed scanning transmission microscopy Rutherford backscattering for structural characterization, i.e., to identify Aβ deposits. Their results confirmed elevated copper (and iron and zinc) content in Aβ deposits.
Other imaging studies have been performed to determine the copper distribution, concentration, and longitudinal changes during disease progression. Similar to the onedimensional analysis of bulk tissue, the findings of these studies were not always in agreement. In their initial PIXE study in 1998, Lovell et al. found fivefold elevated copper content in the neuropil in Alzheimer disease subjects compared with controls (19 μg/g compared with 4 μg/g). A recent study by Wang et al. [110] used cryofixed, unstained brain sections from a transgenic mouse model to investigate the copper distribution during disease progression. The imaging method used was XFM with low-resolution optics (scans were performed at 3μm × 3μm, and 60μm × 60μm resolution, respectively). Wang et al. state that the copper levels in the hippocampus increased from 5 μg/g at 1 month of age to 16 μg/g at 18 months (no standard deviations were given) for the transgenic mice compared with 12 μg/g in 18-month-old control mice. The opposite was found in the thalamus (20 μg/g in transgenic mice versus 60 μg/g in control mice). They did not explain how they identified the hippocampus or the thalamus in their brain sections, and it seems likely that areas that are known to be higher in copper (such as the periventricular areas) were accidently included in some of the calculations. XFM experiments from our laboratory that also used a transgenic mouse model did not result in elevated copper content of the hippocampus; however, we did see a moderate increase in copper concentration from presymptomatic mice (5 μg/g) to symptomatic mice (7 μg/g) (unpublished results).
Conclusions
Multidimensional, high-resolution imaging methods are beginning to elucidate the metallome of copper and its changes during diseases processes. Particularly, XFM methods are rapidly evolving in terms of resolution, three-dimensional capabilities, and user-accessibility, and publications from the past 6 years have established a central role for XFM in metallomic research. The involvement of copper in complex disorders such as Alzheimer disease can only be determined by taking this research to the next level, i.e., from one to two or three dimensions. In combination with correlative techniques such as copper-sensing fluorescent probes or lowerresolution techniques such as LA-ICPMS, XFM will likely become the method of choice in the future to study copper pathways in biological systems.
